Skip to content

Effect of lactic acid bacterial beverage consumption on the reduction of summer fatigue

Effect of lactic acid bacterial beverage consumption on the reduction of summer fatigue: Randomized controlled trial - Effect of lactic acid bacterial beverage consumption on the reduction of summer fatigue: Randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057607
Enrollment
180
Registered
2025-04-15
Start date
2025-04-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Continuous intake of lactic acid bacterial beverages for 8 weeks Continuous intake of control beverages for 8 weeks

Sponsors

EUPHORIA Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ?Healthy subjects aged 20-59 ?Subjects who have received a thorough explanation of the study, fully understand its contents, and voluntarily provide written informed consent (obtained via paper or electronic media) ?Subjects confirmed to be in good health based on pre-study screening assessments

Exclusion criteria

Exclusion criteria: ?Subjects who engage in regular exercise (defined as exercising at least twice a week for 30 minutes or more per session) ?Subjects with a BMI less than 18.5 kg/m2 or equal to or greater than 30.0 kg/m2 ?Subjects who have or have a history of serious diseases such as diabetes, liver disease, kidney disease, heart disease, or cardiovascular disorders ?Subjects with current illnesses under treatment or with a history of serious illnesses that required pharmacological treatment ?Subjects who have consumed fermented milk or lactic acid bacterial beverages at least twice a week during the 3 months prior to providing informed consent ?Subjects who have routinely taken over-the-counter medicines, quasi-drugs, or pharmacist-guided medicines for nutritional supplementation or anti-fatigue purposes during the 3 months prior to providing informed consent ?Subjects with a known allergy to dairy products or lactose intolerance ?Subjects who have participated in another clinical study within one month prior to providing informed consent, or who plan to participate in another clinical study after enrollment ?Subjects who are likely to change their lifestyle habits, including diet and exercise, during the study period ?Subjects deemed unsuitable for participation by the study physician based on questionnaire responses ?Subjects who plan to travel abroad, donate blood, become pregnant, or express breast milk during the study period ?Any other subjects deemed inappropriate for participation by the principal researcher

Design outcomes

Primary

MeasureTime frame
Subjective fatigue (Web-based Daily Log Metrics)

Secondary

MeasureTime frame
[Secondary Outcomes] Wearable Device Metrics(Sleep score, sleep duration, sleep latency, wake time, total sleep time, REM sleep, light sleep, deep sleep, heart rate variability, resting heart rate, respiratory rate) Web-based Daily Log Metrics(Dizziness/lightheadedness, tinnitus, stiff shoulders, lower back pain, appetite, irritability, sensitivity to cold, general fatigue, motivation, mental clarity, satisfaction with sleep) Cognitive Task Performance Metrics(Total number of responses, number of correct responses, accuracy rate, weighted score (number of correct responses x accuracy rate) Heart Rate Variability Metrics(Heart rate (HR), RMSSD, SDNN, HF, LF, LF/HF ratio) Salivary Biomarkers(Cortisol, amylase) Profile of Mood States 2 (POMS2) Metrics(Anger-hostility, confusion-bewilderment, depression-dejection, fatigue-inertia, tension-anxiety, vigor-activity, friendliness, total mood disturbance (TMD) score) Visual Analog Scale (VAS) Metrics(Fatigue level) International Physical Activity Questionnaire (IPAQ) Metrics(Total physical activity, walking physical activity, moderate-intensity physical activity, vigorous-intensity physical activity, sedentary time) [Eligibility Confirmation and Safety Assessment Items] Anthropometric Measurements(Height, weight, body mass index (BMI)) Blood Test Parameters(White blood cell count, red blood cell count, hemoglobin (Hb), hematocrit, platelet count, total protein, albumin, blood urea nitrogen (BUN), creatinine, creatine kinase (CK), total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, total bilirubin, blood glucose, hemoglobin A1c) Blood Pressure Measurements(Systolic blood pressure, diastolic blood pressure) Self-Reported Questionnaire Items(Current medication use, type of occupation, lifestyle habits, willingness and understanding for participation in the study) Simplified Stress Checklist

Countries

Japan

Contacts

Public Contactyuki Urushizawa

EUPHORIA Co., Ltd. Corporate Business Division

yuki.urushizawa@eu-phoria.jp03-6388-9260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026